Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
Functional heterogeneity of vaccine-induced CD8(+) T cellsVladia Monsurrò, Dirk Nagorsen, Ena Wang, et al.Journal of Translational Medicine|April 14, 2010
Comparison of T-cell receptor repertoire restriction in blood and tumor tissue of colorectal cancer patientsSebastian Ochsenreither, Alberto Fusi, Susanne Wojtke, et al.Genome Biology|February 8, 2005
Polarized monocyte response to cytokine stimulationDirk Nagorsen, Sara Deola, Kina Smith, et al.Cancer Immunology, Immunotherapy : CII|July 20, 2006
Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cellsIl-Kang Na, Ulrich Keilholz, Anne Letsch, et al.Current Clinical Pharmacology|May 19, 2018
Pharmacokinetic and Pharmacodynamic Relationship of Blinatumomab in Patients with Non-Hodgkin LymphomaYoussef Hijazi, Matthias Klinger, Andrea Kratzer, et al.Yonsei Medical Journal|July 14, 2004
Mechanism of immune response during immunotherapyMonica C Panelli, Dirk Nagorsen, Ena Wang, et al.Journal of Translational Medicine|January 22, 2005
T cell responses against tumor associated antigens and prognosis in colorectal cancer patientsDirk Nagorsen, Carmen Scheibenbogen, Anne Letsch, et al.Journal of Translational Medicine|June 15, 2005
Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoformsDavid F Stroncek, Christopher Basil, Dirk Nagorsen, et al.Seminars in Cancer Biology|March 6, 2004
Active-specific immunization against melanoma: is the problem at the receiving end?Vladia Monsurrò, Ena Wang, Monica C Panelli, et al.International Journal of Cancer|May 7, 2002
Long-term freedom from recurrence in 2 stage IV melanoma patients following vaccination with tyrosinase peptidesCarmen Scheibenbogen, Dirk Nagorsen, Barbara Seliger, et al.Pageof 7